Client News

Newron Provides Update on FDA Clinical Hold and Phase 3 ENIGMA-TRS Development Program 

InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026

Formycon Optimizes Biosimilar Development with AI-Powered Technologies: Digital Solutions Enhance Development Efficiency as Part of the FYB4GROWTH Strategy

Fierce Biotech Names ReproNovo A “Fierce 15” Company Of 2026

iOmx Therapeutics Appoints Rüdiger Wolff as Chief Financial Officer

Global launch of cosmetic product based on AFYREN’s 100% natural propionic acid

InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development

Galimedix Therapeutics presents baseline data from Phase 2 eDREAM trial highlighting patient-tailored microperimetry as a sensitive and precise functional measurement in geographic atrophy studies

Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026

Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial